Background:Fusarium species are isolated from about 3% of onychomycoses in the Swiss native population. On the basis of macroscopic characters and microscopic examination of the cultures, identification of Fusarium often remains difficult or uncertain because of variations from one isolate to another and overlapping characteristics between species. Objective: To obtain information about the prevailing species of Fusarium collected from onychomycoses. Methods: An analysis of the Fusarium specimens isolated in the Department of Dermatology at the University Hospital of Lausanne was conducted during a 2-year period (71 isolates). A 311-bp fragment of the gene encoding 28S rRNA was amplified by PCR and sequenced. DNA sequences were compared to those available for reference strains. Results:Fusarium oxysporum was the most frequently isolated species, accounting for 54% of the isolates. F. proliferatum and 4 taxons belonging to the F. solani species complex were identified with an appreciable frequency ranging from 4 to 14%. Conclusion: The Fusarium species identified were the same as those known to cause disseminated fusariosis in immunocompromised patients. The presence of these Fusarium species in onychomycoses warrants that careful attention should be paid to abnormal nails before beginning immunosuppressive treatments in patients.

1.
Gupta AK, Ryder JE, Baran R, Summerbell RC: Non-dermatophyte onychomycosis. Dermatol Clin 2003;21:257–268.
2.
Nelson PE, Dignani MC, Anaissie EJ: Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994;7:479–504.
3.
Hennequin C, Abachin E, Symoens F, et al: Identification of Fusarium species involved in human infections by 28S rRNA gene sequencing. J Clin Microbiol 1999;37:3586–3589.
4.
Summerbell RC, Schroers HJ: Analysis of phylogenetic relationship of Cylindrocarpon lichenicola and Acremonium falciforme to the Fusarium solani species complex and a review of similarities in the spectrum of opportunistic infections caused by these fungi. J Clin Microbiol 2002;40:2866–2875.
5.
Monod M, Baudraz-Rosselet F, Ramelet AA, Frenk E: Direct mycological examination in dermatology: A comparison of different methods. Dermatologica 1989;179:183–186.
6.
Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673–4680.
7.
Hall TA: BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 1999;41:95–98.
8.
Swofford DL: PAUP: Phylogenetic Analysis Using Parsimony (and Other Methods). Sunderland, Sinauer Associates, 1998.
9.
Page RDM: Treeview: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996;12:357–358.
10.
Kwon SI, van Dohlon CD, Anderson AJ: Gene sequence analysis of an opportunistic wheat pathogen, an isolate of Fusarium proliferatum. Can J Bot 2001;79:1115–1121.
11.
Romano C, Miracco C, Difonzo EM: Skin and nail infections due to Fusarium oxysporum in Tuscany, Italy. Mycoses 1998;41:433–437.
12.
Gianni C, Cerri A, Crosti C: Unusual clinical features of fingernail infection by Fusarium oxysporum. Mycoses 1997;40:455–459.
13.
Baran R, Tosti A, Piraccini BM: Uncommon clinical patterns of Fusarium nail infection: Report of three cases. Br J Dermatol 1997;136:424–427.
14.
Nucci M, Anaissie EJ: Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: Implications for diagnosis and management. Clin Infect Dis 2002;35:909–920.
15.
Guarrro J, Gene J: Fusarium infections: Criteria for the identification of the responsible species. Mycoses 1992;35:109–114.
16.
Girmenia C, Arcese W, Micozzi A, Martino P, Bianco P, Morace G: Onychomycosis as a possible origin of disseminated Fusarium solani infection in a patient with severe aplastic anemia. Clin Infect Dis 1992;14:1167.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.